the pharmacokinetics and antihypertensive effects of felodipine , a new dihydropyridine calcium channel blocker , were studied in elderly hypertensive patients , 67 to 79 years of age and in young healthy subjects , 20 to 34 years of age following oral administration of 5 mg twice daily to steady-state .
C0015772
felodipine
C2945601
dihydropyridine calcium channel blocker